InvestorsHub Logo
Followers 0
Posts 1
Boards Moderated 0
Alias Born 07/10/2017

Re: None

Monday, 07/10/2017 4:55:47 PM

Monday, July 10, 2017 4:55:47 PM

Post# of 15662
HEB investors wake up!

The company's stock shot up nearly 25% today on its statement that it had enrolled 12 patients suffering from pancreatic cancer in Ampligen trials in the Netherlands, then settled below its last closing price by the end of the day!

Why would the company take the step of issuing such a press release if it didn't anticipate a positive report based on progress to date? It wasn't a required SEC disclosure, afterall.

The company announced that it expects to release data by the end of the year.